Activation of the human Ah receptor by aza-polycyclic aromatic hydrocarbons and their halogenated derivatives

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 4, 2003, Pages 448-452

  Saeki, Ken Ichi ^a   Matsuda, Tomonari ^b   Kato, Taka Aki ^a   Yamada, Katsuya ^a   Mizutani, Takaharu ^a   Matsui, Saburo ^b   Fukuhara, Kiyoshi ^c   Miyata, Naoki ^a,c  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Aryl hydrocarbon receptor; Aza polycyclic aromatic compound; Halogenated derivative; Structure activity relationship

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE DERIVATIVE; CHRYSENE DERIVATIVE; HALIDE; HETEROCYCLIC COMPOUND; NAPHTHALENE DERIVATIVE; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; QUINOLINE DERIVATIVE; HALOGENATED HYDROCARBON;

ARTICLE; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DOSE RESPONSE; DRUG POTENTIATION; METABOLISM;

AZA COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCARBONS, HALOGENATED; POLYCYCLIC HYDROCARBONS, AROMATIC; RECEPTORS, ARYL HYDROCARBON;

EID: 0642347801     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.448     Document Type: Article

References (28)

1. Pohjanvirta R., Tuomisto J., Pharmacol Rev., 46, 483-549 (1994)
2. Gonzalez F. J., Fernandez-Salguero P., Drug Metab. Dispos , 12, 1194-1198 (1998)
3. Okey A. B., Riddick D. S , Harper P. A., Trends Pharmacol. Sci., 15, 226-232 (1994).
4. Huff J., Lucier G., Tritscher A., Annu. Rev. Pharmacol Toxicol., 34, 343-372 (1994).
5. Hankinson O., Annu. Rev. Pharmacol Toxicol., 35, 307-340 (1995).
6. Sogawa K., Fujii-Kuriyama Y., J. Biochem. (Tokyo), 122, 1075-1079 (1997)
7. Jerina D M., Yagi H., Lehr R. E , Thakker D R., Schaefer-Ridder M., Karle J. M., Levin W , Wood A. W., Chang R. L., Conney A. H., "Polycyclic Hydrocarbons Cancer," Vol. 1, ed. by Gelbin H. V., Ts'o Paul O. P., Academic press, New York, 1978, pp 173-188.
8. Miller C. A. III, J Biol. Chem., 272, 32824-32829 (1997).
9. Miller C. A. III, Martin M. A , Hyman L. E., Nucleic Acids Res., 26, 3577-3583 (1998).
10. Miller C. A III, Tox Appl. Pharmacol , 160, 297-303 (1999).
11. Adachi J., Mori Y , Matsui S , Takigami H , Fujino J., Kitagawa H., Miller C. A. III, Kato T., Saeki K., Matsuda Y., J. Biol. Chem., 276, 31475-31478 (2001).
12. Safe S. H., Ann Rev. Pharmacol Toxicol., 26, 371-399 (1986).
13. Karpukins P. P., Slachinskaya A I., Vestn Khar'k. Politekh. Inst., 92, 28-31 (1974)
14. Fukuhara K., Miyata N., Bull. Natl. Inst. Health Sci., 115, 72-85 (1997).
15. Nekrasov S V., El'tsov A. V , Zh Org Khim , 7, 188-199 (1971)
16. Saeki K., Kawai H., Kawazoc Y., Hakura A., Biol. Pharm. Bull., 20, 646-650 (1997).
17. Kato T., Saeki K., Kawazoe Y., Hakura A., Mutat Res., 439, 149-157 (1999).
18. Shibata Y., Takeuchi I., Hamada Y., Yakugaku Zasshi, 108, 1148-1153 (1988)
19. Kato T., Hakura A., Mizutani T , Saeki K., Mutat. Res., 465, 173-182 (2000).
20. Takahashi K., Kamiya M., Sengoku Y., Kawazoe Y , Chem. Pharm. Bull., 36, 4630-4633 (1988).
21. Palmer M. H., J. Chem Soc., 1962, 3645-3652 (1962).
22. Takeuchi I., Hamada Y., Hirota M., Chem Pharm Bull , 41, 747-751 (1993)
23. Kennedy S. W , Lorenzen A., Jones S. P., Hahn M. E., Stegeman J J., Toxicol Appl Pharmacol., 141, 214-230 (1996).
24. Jones J. M., Anderson J. W., Environ. Toxicol. Pharmacol , 7, 19-26 (1999).
25. Villeneuve D L., Khim J S , Kannan K., Giesy J. P., Aquatic Toxicol., 54, 125-141 (2001).
26. Ikeda M., Takatsuki M., Yakabe Arimoto Y., Fukuma T., Higashikawa K , Int Arch. Occup Environ. Health , 74, 295-301 (2001).
27. Giller M , Bergman J , Cambillau C , Fernström B., Gustafssoon J.-Å., Mol. Pharmacol., 28, 357-363 (1985).
28. Gillner M., Bergman J., Cambillau C., Alexandersson M., Fernstoröm B., Gustafsson J-Å., Mol Pharmacol., 44, 336-345 (1993).